EUVIMEDEUVIMED entdecken
Crossref

Brain-Targeting Metal–Organic Framework Nanoplatform Reprogramming Ferroptosis Sensitivity of Glioblastoma

Mengzhen Wang, Yi Lai, Hanxue Meng, Aojia Jin, Ping Zhang, Yinuo Shen, Shutong Lin, Haijun Yu iD, Wujun Xu iD, Vesa-Pekka Lehto iD, Wen Zhang iD, Zhiai Xu iD

ACS Nano · 27.01.2026 · 20 (3) · 2856-2871

DOI: 10.1021/acsnano.5c17966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 13.01.2026. Verfasst von Mengzhen Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering,East China Normal University, Shanghai 200241, China. Hauptthemen laut MEDLINE: Ferroptosis, Glioblastoma, Brain Neoplasms, Metal-Organic Frameworks. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, Shanghai Oriental Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisGlioblastomaBrain NeoplasmsMetal-Organic FrameworksAntineoplastic AgentsNanoparticlesAnimalsHumansMiceCell Line, TumorCoenzyme A LigasesNF-E2-Related Factor 2

Stichwörter der Autor:innen

FerroptosisGlioblastomaLipid metabolismMetal−organic frameworkRadiotherapy

Substanzen

Metal-Organic FrameworksAntineoplastic AgentsCoenzyme A LigasesNF-E2-Related Factor 2

Autor:innen und Institutionen

  • School of Chemistry and Molecular Engineering,East China Normal University, Shanghai 200241, China.
  • State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Department of Technical Physics, University of Eastern Finland, Kuopio 70211, Finland.
  • Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University, Shanghai 200062, China.

ORCID-Profile: Haijun Yu, Wujun Xu, Vesa-Pekka Lehto, Wen Zhang, Zhiai Xu

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • Shanghai Oriental Talents Program

Zitieren

APA

Wang, M., Lai, Y., Meng, H., Jin, A., Zhang, P., Shen, Y., Lin, S., Yu, H., Xu, W., Lehto, V. P., Zhang, W., & Xu, Z. (2026). Brain-Targeting Metal–Organic Framework Nanoplatform Reprogramming Ferroptosis Sensitivity of Glioblastoma. ACS Nano, 20(3), 2856-2871. https://doi.org/10.1021/acsnano.5c17966

Vancouver

Wang M, Lai Y, Meng H, Jin A, Zhang P, Shen Y, et al. Brain-Targeting Metal–Organic Framework Nanoplatform Reprogramming Ferroptosis Sensitivity of Glioblastoma. ACS Nano. 2026;20(3):2856-2871. doi:10.1021/acsnano.5c17966

BibTeX
@article{Wang2026,
  author = {Wang, Mengzhen and Lai, Yi and Meng, Hanxue and Jin, Aojia and Zhang, Ping and Shen, Yinuo and Lin, Shutong and Yu, Haijun and Xu, Wujun and Lehto, Vesa-Pekka and Zhang, Wen and Xu, Zhiai},
  title = {Brain-Targeting Metal–Organic Framework Nanoplatform Reprogramming Ferroptosis Sensitivity of Glioblastoma},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {2856--2871},
  doi = {10.1021/acsnano.5c17966}
}
Kostenlos starten →